West Pharmaceutical Services Inc (NYSE:WST)
| 373.60 BATS BZX Real-Time Price As of 10:26am ET |  +0.01 / +0.00%Today’s Change | 253.86 Today|||52-Week Range 475.35 | -20.34% Year-to-Date |
WST Regular Dividend: WST began trading ex-dividend on 01/18/22. A $0.18 dividend will be paid to shareholders of record as of 01/19/22.
Latest WST News | Press Releases
| PFG Advisors Buys Pacer Lunt Large Cap Alternator ETF, First Trust NASDAQ Rising Dividend ... 7:38am / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 373.59 |
| Today’s open | 379.36 |
| Day’s range | 372.21 - 380.39 |
| Volume | 95,882 |
| Average volume (3 months) | 383,642 |
| Market cap | $28.1B |
Data as of 10:26am ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | +43.43% |
| Earnings growth (this year) | +78.39% |
| Earnings growth (next 5 years) | +27.65% |
| Revenue growth (last year) | +16.44% |
| P/E ratio | 46.5 |
| Price/Sales | 10.00 |
| Price/Book | 15.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZBHZimmer Biomet Holdin... | -0.69 | -0.56% |
| PODDInsulet Corp | -6.84 | -2.94% |
| TFXTeleflex Inc | -4.83 | -1.49% |
| ABMDABIOMED Inc | -0.19 | -0.06% |
Data as of 10:26am ET, 01/21/2022
Financials
| Next reporting date | February 17, 2022 |
| EPS forecast (this quarter) | $1.92 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $346.2M |
| Net profit margin | 16.13% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Exton, Pennsylvania |
Forecasts
